Side-Effects of COVID-19 on Patient Care: An INR Story

Lauren N Pearson1, Stacy A Johnson2, Dina N Greene3

  • 1Department of Pathology, University of Utah, Salt Lake City, UT, USA.

Insights

The COVID-19 pandemic reduced International Normalized Ratio (INR) testing, particularly for outpatients. This led to more high INR results, increasing bleeding risks and highlighting the need for improved monitoring strategies.

Area of Science:

  • Clinical Medicine
  • Pharmacology
  • Public Health

Background:

  • The COVID-19 pandemic significantly disrupted patient care, affecting access to essential medical services and treatments.
  • Reduced access to care may lead to suboptimal management of conditions like venous thromboembolism, potentially impacting therapies such as warfarin.
  • International Normalized Ratio (INR) testing is crucial for monitoring warfarin therapy effectiveness and safety.

Purpose of the Study:

  • To investigate the impact of the COVID-19 pandemic on the utilization of International Normalized Ratio (INR) testing.
  • To determine changes in the percentage of high (≥3.5) and low (≤1.5) INR results during the pandemic.
  • To compare INR testing patterns between inpatient and outpatient settings during the pandemic.

Main Methods:

  • Retrospective analysis of INR data from 11 institutions, comparing pre-pandemic (Jan-June 2019) and pandemic (Jan-June 2020) periods.
  • Evaluation of testing volumes and the proportion of supratherapeutic (≥3.5) and subtherapeutic (≤1.5) INR results.
  • Stratification of data into inpatient and outpatient cohorts for comparative analysis.

Main Results:

  • INR testing volumes remained stable in early 2020 but significantly decreased from March to May, returning to baseline in June.
  • Outpatient INR testing experienced a more substantial decline in volume compared to inpatient testing.
  • An increase in the percentage of high INR results (≥3.5) was observed at 10 of 11 sites, predominantly in the outpatient group, correlating with decreased testing volumes.

Conclusions:

  • The COVID-19 pandemic adversely affected INR testing, particularly among outpatients, potentially due to reduced laboratory access and healthcare utilization.
  • The observed increase in supratherapeutic INR results during the pandemic raises concerns about elevated bleeding event risks in patients on warfarin.
  • Future strategies, including drive-through testing and widespread home INR monitoring, may mitigate these risks and improve patient safety.
Abstract

Related Concept Videos

Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
116
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
436
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
130
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
59
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
102
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
56